Form 3 - Initial statement of beneficial ownership of securities
SEC Accession No. 0001104659-26-034498
Filing Date
2026-03-25
Accepted
2026-03-25 16:02:26
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm268906-6_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm268906-6_3seq1.xml 3 10918
  Complete submission text file 0001104659-26-034498.txt   12365
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Issuer) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address CHEMIN DES MINES 9 GENEVA Switzerland CH-1202
Business Address
Teyssedou Lenaic Nathanael (Reporting) CIK: 0002123881 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39179 | Film No.: 26792383